PITTSBURGH, June 18, 2018 /PRNewswire/ -- An inventor from Hutto, Texas, has developed the patent pending POSTSURGICAL SANITARY CATCH ALL, a modified wound dressing designed for postsurgical nasal drainage.
"After receiving pituitary tumor surgery, I experienced continuous drainage from my nostrils. Each time the gauze was replaced, with surgical tape, I was in so much pain. This inspired me to develop something less painful," said the inventor. The POSTSURGICAL SANITARY CATCH ALL provides a dressing designed to suit the specific needs of a patient. It simplifies the postsurgical care process. This improved dressing will eliminate the possibility of facial skin damage. Its lightweight and easy-to-use design will be pain-free and comfortable for the patient.
The original design was submitted to the Austin office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-AUP-819, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
LifeSpeak Inc. ("LifeSpeak" or the "Company") , the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today that it will release its first quarter 2024 financial results before market open on...
The Honourable Mark Holland, Minister of Health, will host an event in Oshawa to highlight Budget 2024's investments in Canada's electric vehicle supply chain and the future of Canada's automotive industry.
A media availability will follow the...
Hartford HealthCare is among the top 20% of hospitals nationwide recognized for outstanding patient safety ratings and the highest level of adherence to federal price transparency rules....
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting.
Details for the public webcast are as follows:
TIME:...
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....
